Abstract P1-03-04: Role of PTEN and BRCA1 as determinants of synergy for the combination of vistusertib with carboplatin and olaparib in TNBC

MLA

P De, et al. “Abstract P1-03-04: Role of PTEN and BRCA1 as Determinants of Synergy for the Combination of Vistusertib with Carboplatin and Olaparib in TNBC.” Cancer Research, vol. 78, Feb. 2018, pp. P1-03. EBSCOhost, https://doi.org/10.1158/1538-7445.sabcs17-p1-03-04.

APA

P De, N Dey, Brian Leyland-Jones, Jennifer H. Carlson, & Mark J. O’Connor. (2018). Abstract P1-03-04: Role of PTEN and BRCA1 as determinants of synergy for the combination of vistusertib with carboplatin and olaparib in TNBC. Cancer Research, 78, P1-03. https://doi.org/10.1158/1538-7445.sabcs17-p1-03-04

Chicago

P De, N Dey, Brian Leyland-Jones, Jennifer H. Carlson, and Mark J. O’Connor. 2018. “Abstract P1-03-04: Role of PTEN and BRCA1 as Determinants of Synergy for the Combination of Vistusertib with Carboplatin and Olaparib in TNBC.” Cancer Research 78 (February): P1-03. doi:10.1158/1538-7445.sabcs17-p1-03-04.